Milo Biotechnology Announces DSG, Inc. Orphan Drug Designation for AAV1-FS344 for Treatment of Duchenne and Becker Muscular Dystrophy
12/12/2012 9:46:02 AM
More...
|
Auxilium Pharmaceuticals (AUXL) Selects DSG, Inc. as EDC Provider
10/8/2012 11:37:26 AM
More...
|
Media Invited to Meet DSG, Inc.’s Head of Clinical Data Management at SCDM 2012 Conference, Los Angeles
9/20/2012 10:20:36 AM
More...
|
Latest Innovations From DSG, Inc. Unveiled This Week at SCDM 2012
9/18/2012 12:07:38 PM
More...
|
Company Profile for DSG, Inc.
8/24/2012 12:11:30 PM
More...
|
Ariosa Diagnostics, Inc. Selects DSG, Inc. as EDC Provider
4/23/2012 10:33:14 AM
More...
|
DSG, Inc. Partners with Biotech Company to Battle Progressive and Chronic Kidney Disease
2/1/2010 10:01:13 AM
More...
|
DSG, Inc. in the Spotlight at 2009 SCDM Annual Conference
10/1/2009 11:24:44 AM
More...
|
Cipher Pharmaceuticals (DND.TO) Uses DSG, Inc.'s EDC in Effort to Give Hope to Severe Acne Sufferers
9/14/2009 10:11:26 AM
More...
|
DSG, Inc. Tops Clinical Trial Market on the Inc. 500
8/31/2009 9:16:35 AM
More...
|
|